Drug intelligence / Profile preview

SARNA Sensitive Lotion

Development stage
Unknown
Lead developer
Revance
Modality
Small Molecules
Administration
Topical
01

Overview

SARNA Sensitive Lotion is a topical anti-itch formulation containing 1% pramoxine hydrochloride, a small molecule local anesthetic. Developed and studied by Wake Forest University specifically for the treatment of uremic pruritus in adult hemodialysis patients, the lotion works by stabilizing the neuronal membrane of local nerve endings in the skin, thereby inhibiting the initiation and conduction of nerve impulses to provide relief from itching. In a randomized, double-blind, controlled trial (NCT00693654), the pramoxine-based lotion demonstrated a 61% decrease in itch intensity compared to a bland emollient control. The 'Sensitive' formulation is specifically designed without menthol or camphor to be suitable for patients with sensitive or compromised skin, such as those undergoing hemodialysis.

Brand names
SARNA Sensitive LotionSARNA Sensitive
Other names
Pramoxine hydrochloride 1% lotion1% pramoxine hydrochloride lotion
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on SARNA Sensitive Lotion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SARNA Sensitive Lotion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call